[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fJNEwGXNxxag2palyWjHopK3D6s__l89q3mcQlTrwd4I":8,"$fbN6A13MpRtFIX5fJ9EHup9TbwwVNmPzKnjNFKnAASqw":55,"$fuzwxHYhmlbDVQBQfjxa_GbCohAuXcRKwlXbmqdkuI84":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},54571,867193,[],"https://ystcdn.venuertc.com/medical/ystApp/RrM5xDxVhrr4fpz5auCKTz2MWSI8FfTX.png","马晓阳","安丘市人民医院","普外科","住院医师",311,0,"乳腺癌靶向药物使用全攻略","","https://ystcdn.venuertc.com/venue/AI/9d7df829-0608-49f0-812f-4e0da85eaa6d.jpg","\u003Cdiv id=\"material_title\" class=\"medicine-guide-title\">\n  乳腺癌靶向药物使用全攻略\n\u003C/div>\n\n\u003Cdiv class=\"medicine-intro-section medicine-bg1\">\n  \u003Ch2 class=\"medicine-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">直击主题：乳腺癌靶向药物，这些细节真的很重要\u003C/h2>\n  \u003Cdiv class=\"medicine-section-content\">\n    \u003Cp>\n      如果你或者家人正在使用乳腺癌\u003Cstrong>靶向药物\u003C/strong>如曲妥珠单抗（Trastuzumab）、伊尼妥单抗（Pyrotinib）等，安全正确地用药比什么都关键。这类药品属于\u003Cstrong>精准治疗\u003C/strong>\"明星\"，能大大提升疗效，但也对用药过程要求严格。今天，围绕4个核心细节，从剂型、用法、相互作用、常见副作用到特殊管理场景，带你全面掌握靶向药物的日常管理方法。\n    \u003C/p>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"medicine-section medicine-bg2\">\n  \u003Ch3 class=\"medicine-section-title\" id=\"section1\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01 剂型规格大解析💊\u003C/h3>\n  \u003Cdiv class=\"medicine-section-content\">\n    \u003Cul>\n      \u003Cli>\n        \u003Cstrong>曲妥珠单抗\u003C/strong>主要为注射剂型。通常以粉针剂的形式，使用前需溶解配成溶液，静脉滴注（输液）给药。常见规格有150mg/瓶、440mg/瓶。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>伊尼妥单抗\u003C/strong>为口服片剂，每片80mg、160mg不等。服药前请仔细确认药品外包装及剂量。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>同时使用其他药物\u003C/strong>时，注意区分片剂和注射剂，\u003Cspan class=\"highlight-warning\">不可自行更改剂型或掰分注射剂用量\u003C/span>。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp>正确做法：用药前核对药名、规格，按医生指示，不自行更换品牌或剂型。\u003C/p>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"medicine-section medicine-bg3\">\n  \u003Ch3 class=\"medicine-section-title\" id=\"section2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02 作用机制科普🌱\u003C/h3>\n  \u003Cdiv class=\"medicine-section-content\">\n    \u003Cul>\n      \u003Cli>\n        \u003Cstrong>曲妥珠单抗\u003C/strong>是一种针对HER2受体的单克隆抗体。它可以特异性结合HER2蛋白，阻断细胞增长信号，从而抑制异常细胞增殖\u003Csup>[1]\u003C/sup>。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>伊尼妥单抗\u003C/strong>属于小分子酪氨酸激酶抑制剂，靶向HER2受体的激酶活性位点，干扰细胞内信号通路，遏制靶细胞分裂\u003Csup>[2]\u003C/sup>。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp>例子：临床上，患者常常联合使用化疗药和靶向药以增强效果，但每种药物的作用环节不同，必须严格按照医嘱配合。\u003C/p>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"medicine-section medicine-bg4\">\n  \u003Ch3 class=\"medicine-section-title\" id=\"section3\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03 正确用法用量操作指南🕒\u003C/h3>\n  \u003Cdiv class=\"medicine-section-content\">\n    \u003Cul>\n      \u003Cli>\n        \u003Cstrong>曲妥珠单抗\u003C/strong>\n        \u003Cul>\n          \u003Cli>首次用药剂量通常为8mg/kg，通过静脉滴注完成，后续每3周4-6mg/kg维持。\u003C/li>\n          \u003Cli>滴注时间一般为90分钟，后续如耐受正常可缩短至30分钟。\u003C/li>\n        \u003C/ul>\n        \u003Cspan class=\"case-note\">案例：一例患者接受6周期曲妥珠单抗联合化疗，所有给药均由护士操作，未发生堵管等不良状况。\u003C/span>\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>伊尼妥单抗\u003C/strong>\n        \u003Cul>\n          \u003Cli>服用方法为口服，一次160mg或根据体重调整，每日1~2次，餐后30分钟内服用效果较佳。\u003C/li>\n          \u003Cli>不可自行增减剂量，如漏服应于6小时内补服，超时跳过，避免两剂同时服。\u003C/li>\n        \u003C/ul>\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp>特别提醒：所有剂量调整必须由医生决定，切忌自作主张。\u003C/p>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"medicine-section medicine-bg5\">\n  \u003Ch3 class=\"medicine-section-title\" id=\"section4\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04 药物相互作用与用药组合⚠️\u003C/h3>\n  \u003Cdiv class=\"medicine-section-content\">\n    \u003Cul>\n      \u003Cli>\n        \u003Cstrong>曲妥珠单抗\u003C/strong>常与多西他赛、紫杉醇等化疗药物联合应用。注意：联合用药方案严格遵循医嘱，不可自行叠加。部分抗生素、抗心律失常药可能影响心脏功能，用药前需告知医生。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>伊尼妥单抗\u003C/strong>对细胞色素P450酶有抑制/诱导作用，\u003Cspan class=\"highlight-warning\">避免与苯妥英钠、利福平、圣约翰草等合用\u003C/span>。部分质子泵抑制剂也会影响它的代谢。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>典型问题\u003C/strong>：有患者在同时服用谷胱甘肽、复方苦参等辅助药物，实际效果和安全性需定期监测，避免因药物叠加引发副作用。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp>正确做法：如需新增其他药物，提前与医生或药师多沟通。\u003C/p>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"medicine-section medicine-bg6\">\n  \u003Ch3 class=\"medicine-section-title\" id=\"section5\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05 用药禁忌与使用前检查❌\u003C/h3>\n  \u003Cdiv class=\"medicine-section-content\">\n    \u003Cul>\n      \u003Cli>\n        \u003Cstrong>曲妥珠单抗\u003C/strong>\n        \u003Cul>\n          \u003Cli>禁用于既往对该药有严重过敏反应者。\u003C/li>\n          \u003Cli>已知心功能不全者，要避免使用或严格管理，给药前后须做心脏超声评估。\u003C/li>\n        \u003C/ul>\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>伊尼妥单抗\u003C/strong>\n        \u003Cul>\n          \u003Cli>严重肝功能不全、肾衰患者慎用，服药前建议做肝肾功能检查。\u003C/li>\n        \u003C/ul>\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>特殊人群\u003C/strong>：孕妇、哺乳期女性用药需经医生评估风险；18岁以下儿童不建议使用。\u003C/li>\n    \u003C/ul>\n    \u003Cp>正确做法：首次用药前如实告知既往用药及过敏史，并报告任何特殊身体状况。\u003C/p>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"medicine-section medicine-bg7\">\n  \u003Ch3 class=\"medicine-section-title\" id=\"section6\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06 常见不良反应与处理方式😷\u003C/h3>\n  \u003Cdiv class=\"medicine-section-content\">\n    \u003Cul>\n      \u003Cli>\n        \u003Cstrong>曲妥珠单抗\u003C/strong>较常见的副作用有静脉反应、发热、寒战、恶心等。还可能影响心脏功能（如心力衰竭发生率约为4%~7%），早期识别及时处理至关重要\u003Csup>[1]\u003C/sup>。\u003C/li>\n      \u003Cli>\n        \u003Cstrong>伊尼妥单抗\u003C/strong>以腹泻、皮疹为主（发生率各在30%左右\u003Csup>[2]\u003C/sup>）。部分患者出现口腔炎、食欲减退。\u003C/li>\n      \u003Cli>\n        \u003Cstrong>用药案例\u003C/strong>：临床中有女性患者长程用药后出现脱发，药师指导补充营养后可缓解，但如出现持续呕吐、腹泻、皮疹加重请立即就医。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp>正确做法：如遇轻度不良反应短期内可自我观察，但症状明显或持续，必须联系医生。\u003C/p>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"medicine-section medicine-bg8\">\n  \u003Ch3 class=\"medicine-section-title\" id=\"section7\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07 储存与管理全流程🏠\u003C/h3>\n  \u003Cdiv class=\"medicine-section-content\">\n    \u003Cul>\n      \u003Cli>\n        \u003Cstrong>曲妥珠单抗粉针\u003C/strong>需避光、冷藏（2~8°C）保存；溶解后如未用尽，需在24小时内冷藏，并避免冷冻。\u003C/li>\n      \u003Cli>\n        \u003Cstrong>伊尼妥单抗片剂\u003C/strong>置于干燥、阴凉处保存，不要去除原包装，也不要和其他药品混放。儿童不可触及。\u003C/li>\n    \u003C/ul>\n    \u003Cp>正确做法：每次取药后确保包装密封完好，未用完的药物按照医嘱处理，切忌随意丢弃。\u003C/p>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"medicine-section medicine-bg1\">\n  \u003Ch3 class=\"medicine-section-title\" id=\"section8\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">08 漏服、过量及应急处理🚨\u003C/h3>\n  \u003Cdiv class=\"medicine-section-content\">\n    \u003Cul>\n      \u003Cli>\n        \u003Cstrong>曲妥珠单抗\u003C/strong>注射因由医护人员操作，通常无漏用风险。如确有已跳过疗程或过量，及时通知治疗医师，按医生指令补齐或评估安全。\u003C/li>\n      \u003Cli>\n        \u003Cstrong>伊尼妥单抗\u003C/strong>片剂若漏服，可于6小时内补服，超过则跳过该次，切勿一次服两倍剂量。如出现明显不适或疑似过量时，尽快前往医院处理。\u003C/li>\n    \u003C/ul>\n    \u003Cp>正确做法：保持详细的用药记录，遇到用药问题第一时间联系专业人士。\u003C/p>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"medicine-section medicine-conclusion medicine-bg2\">\n  \u003Ch3 class=\"medicine-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">🔑 总结与提醒\u003C/h3>\n  \u003Cdiv class=\"medicine-section-content\">\n    \u003Cul>\n      \u003Cli>\n        靶向药物（如曲妥珠单抗、伊尼妥单抗）需严格按照剂型、用量和时程执行，不得随意更改。\n      \u003C/li>\n      \u003Cli>\n        谨防药物相互作用，并注意不良反应的监控，如遇任何不适，优先提交给专业医生处理。\n      \u003C/li>\n      \u003Cli>\n        妥善储存，定期回顾用药记录，是长期管理的关键。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp>\n      合理用药，规避风险，有疑虑及时咨询医生或药师，让治疗更安心。\n    \u003C/p>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"medicine-section medicine-bg3 medicine-reference\">\n  \u003Ch3 class=\"medicine-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">📚 主要参考文献\u003C/h3>\n  \u003Cdiv class=\"medicine-section-content\">\n    \u003Col>\n      \u003Cli>\n        Slamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., et al. (2001). Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. \u003Cem>New England Journal of Medicine\u003C/em>, 344(11), 783-792.\n      \u003C/li>\n      \u003Cli>\n        Ma, F., Ouyang, Q., Li, W., et al. (2019). Pyrotinib or lapatinib plus capecitabine in HER2-positive metastatic breast cancer (PHOEBE): a randomized, open-label, controlled, phase 3 trial. \u003Cem>Lancet Oncology\u003C/em>, 20(3), 348-360.\n      \u003C/li>\n      \u003Cli>\n        Hurvitz, S. A., Dirix, L., Kocsis, J., et al. (2018). Phase II randomized study of lapatinib and trastuzumab in combination with an aromatase inhibitor in postmenopausal women with HER2-positive, hormone receptor–positive metastatic breast cancer. \u003Cem>Journal of Clinical Oncology\u003C/em>, 36(8), 741-748.\n      \u003C/li>\n    \u003C/ol>\n    \u003Cp>引用文献均可通过 PubMed 或 Google Scholar 检索。\u003C/p>\n  \u003C/div>\n\u003C/div>\n\n\u003Cstyle>\n.medicine-guide-title {\n  font-size: 2.3em;\n  font-weight: bold;\n  text-align: center;\n  margin-top: 32px;\n  color: #207378;\n  letter-spacing: 2px;\n  margin-bottom: 36px;\n}\n\n.medicine-section {\n  margin: 28px auto 32px auto;\n  padding: 22px 28px 18px 28px;\n  max-width: 860px;\n  border-radius: 11px;\n  box-shadow: 0 2px 11px rgba(50, 191, 239, 0.06);\n  font-size: 1.18em;\n}\n\n.medicine-bg1 {\n  background: linear-gradient(98deg,#e0f7fa 0%, #f9fbe7 100%);\n}\n\n.medicine-bg2 {\n  background: linear-gradient(120deg,#f3e5f5 0%, #fce4ec 100%);\n}\n\n.medicine-bg3 {\n  background: linear-gradient(100deg,#e0f2f1 0%, #e3f2fd 100%);\n}\n\n.medicine-bg4 {\n  background: linear-gradient(112deg, #fffde7 0%, #fbe9e7 100%);\n}\n\n.medicine-bg5 {\n  background: linear-gradient(100deg, #e1f5fe 0%, #defff3 100%);\n}\n\n.medicine-bg6 {\n  background: linear-gradient(99deg, #fce4ec 0%, #ffe0b2 100%);\n}\n\n.medicine-bg7 {\n  background: linear-gradient(90deg,#e3f2fd 0%, #fdefff 100%);\n}\n\n.medicine-bg8 {\n  background: linear-gradient(108deg,#f5f5f5 0%, #e0f2f1 100%);\n}\n\n.medicine-section-title {\n  font-size: 1.3em;\n  color: #207378;\n  font-weight: 700;\n  margin-bottom: 18px;\n  letter-spacing: 1.3px;\n}\n\n.medicine-section-content {\n  color: #33404d;\n  line-height: 1.78;\n}\n\nul, ol {\n  padding-left: 22px;\n  margin: 10px 0 14px 0;\n}\n\nli {\n  margin-bottom: 8px;\n}\n\n.case-note {\n  color: #755eee;\n  font-size: 0.97em;\n  background: #f7f2fd;\n  border-radius: 5px;\n  padding: 4px 7px;\n  margin: 5px 0;\n  display: inline-block;\n}\n\n.highlight-warning {\n  color: #d32f2f;\n  font-weight: bold;\n  background: #fff2e6;\n  border-radius: 4px;\n  padding: 2px 8px;\n}\n\n.medicine-conclusion {\n  border: 1.5px dashed #4dd0e1;\n}\n\n.medicine-reference ol {\n  background: #f9fbe7;\n  border-radius: 5px;\n  padding: 12px 20px 12px 32px;\n}\n\n.medicine-reference p {\n  margin-top: 12px;\n  color: #599ca2;\n}\n\n@media screen and (max-width: 600px) {\n  .medicine-guide-title {\n    font-size: 1.4em;\n  }\n  .medicine-section {\n    padding: 15px 8px 11px 8px;\n    font-size: 1em;\n  }\n  .medicine-section-title {\n    font-size: 1.08em;\n  }\n}\n\u003C/style>\n\n","\u003Cdiv id=\"material_title\" class=\"medicine-guide-title\">\n  乳腺癌靶向药物使用全攻略\n\u003C/div>\n\n\u003Cdiv class=\"medicine-i",495,"2025-07-31 11:14:36","乳腺癌, 靶向药物, 曲妥珠单抗, 伊尼妥单抗, 副作用, 用药管理, 药物相互作用, 精准治疗","了解乳腺癌靶向药物如曲妥珠单抗、伊尼妥单抗的使用细节，包括剂型、用法、相互作用及副作用，为安全有效的治疗保驾护航。","2025-08-01 21:34:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]